Management Team - Realbio Technology

Nan Qin
CEO of Shanghai Realbio Technology Co. LTD

Research Fellow of the Tenth People's Hospital of Tongji University, Doctoral Supervisor, the winner of the First Prize of Shanghai Science and Technology Progress Award, expert of Shanghai Program for Overseas High-level Talents Introduction, member of the Youth Committee of Tumor Marker Committee of Chinese Anti-Cancer Association, an editorial board member of Chinese Journal of Microecology, and the winner of the Second Shulan Medical Youth Award and "Great Challenge Young Scientist" Award issued by the Ministry of Science and Technology and Gates Foundation.
2008-2011: Person in charge of Microbial Genome Department of the Beijing Genomics Institute (BGI); 2011-2016: Special Research Fellow of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases of the First Affiliated Hospital, Zhejiang University Doctor in Microbiology of Virginia Polytechnic Institute (United States), EMBA of China Europe International Business School
The current research areas include the infectious disease, metabolic disease, autoimmune disease and the relationship between the tumor immunotherapy and infectious diseases. The long-term goal of these researches is to develop new technology concerned with human health for early screening and diagnosis of tumors.
Since 2009, he has presided over or participated in many national and ministerial and provincial-level scientific research projects and talent program projects, and has published more than 50 papers in top international academic journals such as Nature and Science.

Qiang Liu
Chief operating officer
Qiang graduated from Shandong University with a major in microbiology. With over 10 years of industrial experience in diagnostic reagents, he has held important positions such as sales directors in a number of well-known companies and is responsible for corporate marketing and integrated business development. Currently, Qiang is responsible for the construction of RBT's management and organization system.
Jing Liu
Deputy general manager
Ph.D. from Zhejiang University, 2010-2011 State-sponsored Australian Commonwealth Scientific and Industrial Research Organization (CSIRO) for visiting study. From 2014 to 2016, she was engaged in post-doctoral research at Zhejiang University, during which she received second-class funding from the Postdoctoral Science Foundation. With eight years of experience in human microbiome research, a number of research results have been published in mainstream SCI journals such as FEMS Microbiology Ecology, Current Microbiology, BMC Microbiology, etc.
Beiwen Zheng
Chief medical officer
Doctor of Microbiology, Institute of Microbiology, Chinese Academy of Sciences. Participated in or presided over more than 20 national and provincial scientific research projects, acted as the reviewer of more than 20 SCI and Chinese core journals such as JANTIMICROB CHEMOTHER, ENVIRON POLLUT, Emergmicrobes-Infect and published more than 100 SCI papers. The cumulative impact factor is more than 248, the correspondence and one work more than 50, personal H-INDEX: 21, has rich experience in scientific research scheme design.